PENDARVIS DAVID 4
4 · RESMED INC · Filed Nov 15, 2022
Insider Transaction Report
Form 4
RESMED INCRMD
PENDARVIS DAVID
Sr. VP, General Counsel
Transactions
- Tax Payment
ResMed Common Stock
2022-11-11$225.18/sh−450$101,331→ 101,927 total - Tax Payment
ResMed Common Stock
2022-11-11$225.18/sh−279$62,825→ 101,311 total - Tax Payment
ResMed Common Stock
2022-11-11$225.18/sh−337$75,886→ 101,590 total
Footnotes (3)
- [F1]Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/21/2019.
- [F2]Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/19/2020.
- [F3]Disposition to issuer for tax withholding on scheduled vesting of Restricted Stock Units granted 11/18/2021.